About PNAS Nexus - PNAS
PNAS Nexus Submitting to the PNAS portfolio. The National Academy of Sciences (NAS) publishes the Proceedings of the National Academy of Sciences (PNAS) as well as its open access sibling journal PNAS Nexus.PNAS was established in 1914 and is one of the world’s most-cited and comprehensive multidisciplinary scientific journals.
Article and Journal Metrics - PNAS
PNAS provides several article-level metrics for all articles. Click on the “Info & Metrics” tab of any PNAS article to see its Altmetric score, citation counts, and usage data, including downloads of the abstract, full text, and PDF. PNAS encourages responsible authorship practices and provides ...
Latest Articles - PNAS
Dec 17, 2024 · Browse the most-recent publications from PNAS, publishing daily across the physical, social, and biological sciences.
PNAS | December 2024 | vol. 121 | i–xxx Submit to the Proceedings of the National Academy of Sciences (PNAS) and have your research discovered by millions of researchers in the biological, physical, and social sciences. About PNAS PNAS has been at the forefront of scientific research for over a century.
Editorial Board - PNAS
A PDF list of Editorial Board members and staff members is posted on the current issue Table of Contents; click on the [Masthead (PDF)] link in the upper right corner.
PNAS
A detailed retrospective of the Green Revolution, its achievements and limits in agricultural productivity, and its broader social, environmental, and economic impacts.
PNAS
The study explores lipid nanoparticle-mediated lymph node-targeting delivery for enhanced immunotherapy.
PNAS
Proceedings of the National Academy of Sciences (PNAS) publishes high-impact scientific research across a wide range of disciplines.
PNAS
Lipid nanoparticles (LNPs) are a versatile platform for nucleic acid delivery, particularly for mRNA vaccines, but face challenges in endosomal escape.
Addressing epistasis in the design of protein function | PNAS
The impact of mutations on stability or activity may depend on other mutations in a phenomenon known as epistasis. (Left) Schematics of two favorable interactions (Top and Bottom) in which the intermediates (center) are incompatible and thus unlikely to be tolerated in evolution.(Right) Two amino acid residues across the light–heavy chain interface of an antibody variable domain …